Navigation Links
Diabetes Linked to Blood Vessel Inflammation
Date:12/6/2007

Easing the blood sugar disease may help the heart, researchers say

THURSDAY, Dec. 6 (HealthDay News) -- U.S. researchers say they've identified a new pathway that increases a dangerous inflammation of blood vessels in people with diabetes.

A team at the University of California, Davis, Health System believes that good control of diabetes may reduce this inflammation and possibly reduce the risk of cardiovascular disease.

They found that people with type 1 diabetes have increased expression and signaling of two key receptors within the innate immune system. These receptors (TLR2 and TLR4) are part of a family of pattern-recognition receptors called Toll-like receptors (TLRs).

Increased expression of TLR2 and TLR4 in people with type 1 diabetes contributes to inflammation of blood vessels, the study authors said. Their finding is published in the online issue of the Journal of Clinical Endocrinology & Metabolism.

"It is not unreasonable to speculate that TLR2 and TLR4 promote (cardiovascular disease) by contributing to the pro-inflammatory state in type 1 diabetes," lead author Ishwarlal Jialal, director of the Laboratory for Atherosclerosis and Metabolic Research, and professor of internal medicine at UC Davis, said in a prepared statement.

"Inflammation is central to heart disease, playing a pivotal role in plaque formation and stroke. We may well find that a serendipitous byproduct of controlling diabetes is the simultaneous control of this new pathway, leading to less inflammation and lower risk of heart problems," Jialal said.

The researchers plan further studies to investigate the molecular mechanisms that cause increased TLR2 and TLR4 expression and how these receptors contribute to inflammation in people with diabetes.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Disease has more about

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Adverse housing conditions contribute to diabetes risk
2. RAND finds cases of undiagnosed diabetes drop sharply
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Diabetes appears to increase risk of death for patients with acute coronary syndromes
5. Discovery of sugar sensor in intestine could benefit diabetes
6. Despite overeating, morbidly obese mice gain protection against diabetes
7. Heart Attack Boosts Diabetes Risk
8. Obesity Doesnt Always Equal Diabetes
9. Sugary Sodas High in Diabetes-Linked Compound
10. Treating diabetes during pregnancy can break link to childhood obesity
11. Treating Diabetes During Pregnancy Could Lead to Thinner Kids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... recognized as a leader in the Collection Industry for the ... traditional collection agencies in speed, cost, and customer retention. ... ... A.R.M. Solutions, a leading provider of flat-fee collection services, was ... Collections by insideARM.com. This is the second time this year ...
(Date:12/7/2009)... to reverse some of the damage to their lungs ... cigarettes, according to research out of the University of ... published in the December 15 issue of the American ... Care Medicine . , "We found that exposure to ... epithelium, or lining, of the airways in the lung. ...
(Date:12/6/2009)... the loss of a key segment of DNA can lead ... show that this kind of genetic alteration can cause obesity. ... The study, led by Dr Sadaf Farooqi from the University ... Sanger Institute, looked at 300 children with severe obesity. , ... of mutation known as copy number variants (CNVs). CNVs are ...
(Date:12/6/2009)... Dec. 6 Sickle cell disease, a ... cells, is one of the most common genetic ... world, including more than 70,000 Americans.(1) Research presented ... American Society of Hematology highlights intriguing studies on ... for children with this blood disorder, evaluations of ...
(Date:12/6/2009)... Attorney Joseph W. Belluck of Belluck & Fox, LLP says dangerous ... holiday seasons. , ... New York, NY (PRWEB) December ... holiday season, they should be alert to reports of recalls due ... injury lawyer., , ,“Close to 230,000 children visit hospital emergency rooms ...
Breaking Medicine News(10 mins):Health News:Collection Agency Named One of 2009 Best Places to Work 2Health News:Quitting smoking can reverse asthma-inducing changes in lungs 2Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3
... commercial companies over clinical and preclinical trial data—could jeopardize ... harm public health, says Karin Timmermans of the World ... ,Writing in a personal capacity, Ms Timmermans ... generic versions of the "flu drug" oseltamivir in the ...
... Delhi: Only three private hospitals out of the 26 land ... provide free treatment to poor patients,// according to a report ... ,The Delhi Development Authority and the Land & Development ... to various trusts and societies to establish hospitals out of ...
... allow a pioneering doctor, currently under house arrest in Henan ... award for her work on behalf// of HIV/AIDS patients, it ... had permission to travel," retired professor Gao Yaojie, 79, told ... holding her under house arrest for two weeks. ...
... thanking doctors who clutched at the last straw to save their ... Longfellow was born last August when his mother was just into ... weight was bad enough, but this was worsened when his lungs ... duct in the heart had not closed properly. He was operated ...
... promise in slowing progression and prolonging survival time in ... of targeted anti-cancer drugs that blocks the human epidermal ... the lives of patients with recurrent prostate cancer, a ... compound called pertuzumab, works by binding to and inhibiting ...
... mathematical model of disease cycles developed at the University ... ,Speaking in a symposium titled "New Vistas in ... meeting of the American Association for the Advancement of ... discuss how models that she and coworkers have developed ...
Other Medicine News:Health News:Drug Companies Should Not Have a Monopoly Over Clinical Trial Data 2Health News:Private Hospitals Ignore Deal to Provide Free Treatment 2Health News:Viagra Plays Another Role-Premature Baby Saved 2Health News:New Drug Promises Prolonged Survival in Prostate Cancer Patients 2Health News:New Drug Promises Prolonged Survival in Prostate Cancer Patients 3Health News:Mathematical Model Predicts Cholera Outbreaks 2
(Date:12/4/2009)... N.J., Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: ... today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed ... Food and Drug Administration seeking approval to market its ... patent owned by Takeda Pharmaceutical Company Limited. Watson,s ...
(Date:12/4/2009)... anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder ... the comorbidities reported to occur more often in ... epilepsy versus those without an epilepsy diagnosis, according ... the U.S. ,, Findings from " CNS-Related Comorbidities ...
(Date:12/3/2009)... Pharmacyclics, Inc. (Nasdaq: PCYC ), a biopharmaceutical company ... for the treatment of immune mediated diseases and cancer, ... conference call on, Tuesday, December 8, 2009 at 11:00am ... to discuss clinical data regarding its HDAC Program (PCI-24781) ...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 6418 1The Deal Names Abbott Top Dealmaker for Second Consecutive Year 6418 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 6418 3AUDIO from Medialink and Ortho McNeil Janssen Pharmaceuticals Inc 3A Getting Ready for Cold and Flu Season 6416 1Preventing H1N1 spread to health care workers 3A Dilemma debate and confusion 61746 1Preventing H1N1 spread to health care workers 3A Dilemma debate and confusion 61746 2
... Participating in Bavituximab U.S. Cancer Trial Presents ... to Anti-Angiogenesis Experts -, TUSTIN, Calif., ... PPHM ), a clinical stage biopharmaceutical,company developing ... and,hepatitis C virus infection (HCV), today reported ...
... New data showed that at 48,weeks, significantly ... to non-nucleoside reverse transcriptase inhibitors,(NNRTIs) and protease ... as less than 50 HIV-1 RNA copies/mL) ... (BR) compared with placebo plus a BR.,These ...
Other Medicine Technology:Clinical Experience With Peregrine's Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents 2Clinical Experience With Peregrine's Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents 3Clinical Experience With Peregrine's Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents 4New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy 2New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy 3New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy 4New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy 5New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy 6
... density. Proven ergonomic design reduces hand fatigue, prevents injury. Dry seal technology. ... 10-100 Inaccuracy ... 1.2~2.5 Imprecision(%) ... 1 Dimensions: ...
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
... Seven digital models cover the range from 2ul ... fluently. Volume lock design prevents inadvertent volume ... horizontal grip. Whole pipette is autoclavable at ... is all polypropylene. Suitable for one-handed operation. ...
Research Series 2100 Adjustable-volume Pipette, 10-100 l, single-channel with adjustable-volume setting...
Medicine Products: